繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 皮肤性病 >> 新药动态 >> 新一代白癜风细胞悬浮液vitcell即将上市

新一代白癜风细胞悬浮液vitcell即将上市

2016-02-15 06:49:59  作者:新特药房  来源:互联网  浏览次数:4  文字大小:【】【】【
简介:Viticell®细胞悬浮液,用于皮肤色素沉积装置VITICELL®是一种(细胞悬浮液)装置,它可专用于皮肤色素沉积(白癜风或减色创伤后疤痕),根据皮肤的大小面积自体移植,该Viticell®套件必须根据医生的 ...

Viticell®细胞悬浮液,用于皮肤色素沉积装置
VITICELL®是一种(细胞悬浮液)装置,它可专用于皮肤色素沉积(白癜风或减色创伤后疤痕),根据皮肤的大小面积自体移植,该Viticell®套件必须根据医生的建议使用。
制造商:LABORATOIRESGenévrier


Viticell® is a medical device for performing
an autologous transplantation.
In your case, the autologous transplantation or autografting, is a transfer of cells harvested from a normally pigmented skin area to another area of your body (reason for calling it “autograft”) having a pigmentation defect. These cells will take root and multiply in the grafted area and contribute to its re-pigmentation.
Repigmentation should begin to appear within 4 weeks after the intervention. Early signs can take the form of a light brown veil over the treated area. Once healing is achieved, a UV treatment may be considered to allow the fullest possible re-pigmentation.
There are about fifteen studies on re-pigmentation by autologous transplantation. One of the most representative was conducted in 67 patients transplanted and followed for 5 years. Depending on the type of vitiligo, 73% to 84% of the interventions resulted in a re-pigmentation rated as “excellent” (that is to say greater than 95%), maintained for 5 years after intervention1.
1- Mulekar SV. Long-term Follow-up Study of Segmental and Focal Vitiligo Treated by Autologous, Noncultured Melanocyte-Keratinocyte Cell Transplantation. Arch Dermatol. 2004;140:1211-1215.
VITICELL® is a kit for preparation of a cell suspension. This medical device is a regulated health product that bears the CE mark as per the legislation. Class III Medical Device (CE0499). Read carefully the leaflet or ask your doctor for advice.
Manufacturer: Laboratoires Genévrier.

责任编辑:admin


相关文章
 

最新文章

更多

· 新一代白癜风细胞悬浮液...
· 银屑病新药Enstilar获FD...
· 美国FDA批准新类剂量复方...
· 美国FDA批准各种HIV感染...
· FDA批准复方抗艾药Evota...
· 新型Reyataz(atazanavir...
· SCENESSE(afamelanotide...
· 银屑病新药Cosentyx(ust...
· Cosentyx(secukinumab)白...
· Otezla(apremilast)将获...

推荐文章

更多

· 新一代白癜风细胞悬浮液...
· 银屑病新药Enstilar获FD...
· 美国FDA批准新类剂量复方...
· 美国FDA批准各种HIV感染...
· FDA批准复方抗艾药Evota...
· 新型Reyataz(atazanavir...
· SCENESSE(afamelanotide...
· 银屑病新药Cosentyx(ust...
· Cosentyx(secukinumab)白...
· Otezla(apremilast)将获...

热点文章

更多

· 新一代白癜风细胞悬浮液...